{"article_title": "340B Orphan Drug Discounts Dialed Back", "article_keywords": ["340b", "dialed", "drugs", "view", "orphan", "drug", "discounts", "health", "rule", "judge", "care", "york"], "article_url": "http://www.law360.com/articles/714472/340b-orphan-drug-discounts-dialed-back", "article_text": "340B Orphan Drug Discounts Dialed Back\n\nLaw360, New York (October 14, 2015, 9:28 PM ET) -- The Affordable Care Act fully exempts orphan drugs from mandatory discounts under the 340B program for certain health care providers, a D.C. federal judge said Wednesday in an important victory for trade group Pharmaceutical Research and Manufacturers of America.\n\n\n\nThe decision from U.S. District Judge Rudolph Contreras vacated a rule issued last year by the U.S. Department of Health and Human Services. The rule interpreted the ACA as requiring discounts when orphan drugs are used for diseases that aren\u2019t rare, but PhRMA filed suit, arguing that...\n\nTo view the full article, register now.", "article_metadata": {"description": "The Affordable Care Act fully exempts orphan drugs from mandatory discounts under the 340B program for certain health care providers, a D.C. federal judge said Wednesday in an important victory for trade group Pharmaceutical Research and Manufacturers of America.", "apple-itunes-app": "app-id=934560389, app-argument=law360://www.law360.com/articles/714472/340b-orphan-drug-discounts-dialed-back", "csrf-token": "+QcLsXz2GLDcLj3kufhaBmj5Cb4x+71SAkktSafZk0Fwd5bbrQ8scLEMTqQAL39rajlzm3BPl1AOPUrzMD1nTA==", "csrf-param": "authenticity_token", "og": {"url": "http://www.law360.com/articles/714472/340b-orphan-drug-discounts-dialed-back", "image": "https://www.law360.com/images/360.png", "type": "website", "title": "340B Orphan Drug Discounts Dialed Back - Law360"}, "viewport": "width=device-width, initial-scale=1.0"}, "article_summary": "340B Orphan Drug Discounts Dialed BackLaw360, New York (October 14, 2015, 9:28 PM ET) -- The Affordable Care Act fully exempts orphan drugs from mandatory discounts under the 340B program for certain health care providers, a D.C. federal judge said Wednesday in an important victory for trade group Pharmaceutical Research and Manufacturers of America.\nThe rule interpreted the ACA as requiring discounts when orphan drugs are used for diseases that aren\u2019t rare, but PhRMA filed suit, arguing that...To view the full article, register now.\nThe decision from U.S. District Judge Rudolph Contreras vacated a rule issued last year by the U.S. Department of Health and Human Services."}